1. Xi Zhang , Zhuoling An , Yali Lv , Guangrun Li , Lihong Liu* , Pengfei Li *.Simultaneous Determination of RDX and HMX in Rat Plasma by LC-MS/MS and its Applications. Front Chem.2022.10.808226.SCI |
2. Ximu Sun , Zhuo Ma , Qixiang Guo , Zhixia Zhao* , Lihong Liu *.Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.Eur J Cancer.2022.160.277-278.SCI |
3. Pengfei Li#, Jun Peng#, Yuexin Li , Lili Gong, Yali Lv, He Liu, Tianhong Zhang, Song Yang, Hongchuan Liu, Jinglai Li*, Lihong Liu*.Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Finding Out the Causes Leading to the Ultra-low Oral Bioavailability and Identifying the Metabolic Pathway.Frontiers in Pharmacology.2021.12.621003.SCI |
4. Jing Yang , Hui Yang , Zihui Wang , Xin Wang , Yingkai Wang , Xiaojia Yu , Lihong Liu*.Self-management among type 2 diabetes patients via the WeChat application: A systematic review and meta-analysis. J Clin Pharm Ther.2021.46(1).4-16.SCI |
5. Hui Yang, Yiqi Sun, Xiaojia Yu, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang,Lihong Liu*.Clinical impact of adaptation of initial tacrolimus dosing to CYP3A5 genotype after kidney transplantation: systematic review and meta–analysis of randomized controlled trials.Clinical Pharmacokinetics.2021.60(7).877-885.SCI |
6. Hui Yang†, Lizhen Pang†, Xiaopeng Hu, Wei Wang , Bifang Xu, Xiaodong Zhang, Lihong Liu* .Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplantation: a two year prospective cohort study.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES.2021.24.210-216.SCI |
7. Hao Liang #, Xinru Zhang#, Zhuo Ma#, Yan Sun, Chang Shu, Yihua Zhu, Yanwei Zhang, Songnian Hu*, Xiujuan Fu, Lihong Liu*.Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension.Pharmgenomics Pers Med.2021.14.189-197.SCI |
8. Xin Wang, Shihui Wang, Xiaojia Yu, Zhuo Ma, Huaguang Wang, Jing Yang, Lihong Liu *.Impact of pharmacist-led medication therapy management in ambulatory elderly patients with chronic diseases.Br J Clin Pharmacol.2021.87(7).2937-2944.SCI |
9. Hui Yang, Chen Q, Huang A, Yu X, Chen G, Hu X, Wang W, Liu H, Zhang X, Liu L*.The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES.2021.24.292-307.SCI |
10. Qixiang Guo#,Wenchao Lu#,Ximu Sun,Zhixia Zhao*,,Lihong Liu*.Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients.European Journal of Cancer.2021.157.358-360.SCI |
11. Wenchao Lu#,Qixiang Guo#,Zhuo Ma,Lihong Liu*,Zhixia Zhao*.Lenvatinib and Osteonecrosis of the Jaw: A pharmacovigilance study.European Journal of Cancer.2021.150.211-213.SCI |
12. Ximu Sun#, Xinrui Wang ,Jie Zhang ,Zhixia Zhao , Xin Feng *,Lihong Liu *, Zhuo Ma*.Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review.Breast.2021.60.26-34.SCI |
13. Ping Du*, Guoyong Wang, Rui Zhao, Zhuoling An, Lihong Liu*.Eicosanoids metabolomic profile of remdesivir treatment in rat plasma by high-performance liquid chromatography mass spectrometry.Front Pharmacol.2021.12.747450.SCI |
14. Song Yang, Ting Hu, He Liu, Ya-li Lv, Wen Zhang, Han Li, Lingling Xuan, Li-li Gong* , Li-hong Liu*.Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.Biomed Pharmacother.2021.138.111441.SCI |
15. Zhuo Ma#, Ximu Sun#, Zhixia Zhao, Wenchao Lu, Qixiang Guo, Shihao Wang, Jiwen You, Yuhui Zhang*, Lihong Liu*.Risk of pneumonitis in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database.Gynecologic Oncology.2021.162(2).496-505.SCI |
16. Zhuo Ma#, Ximu Sun#, Wenchao Lu, ZhiXia Zhao, Zhouming Xu, Jiayou Lyu, Peng Zhao, Lihong Liu*.Poly (ADP-ribose) Polymerase Inhibitors-Associated Myelodysplastic Syndrome/Acute Myeloid Leukemia: A Pharmacovigilance Study of the FAERS database.ESMO Open.2021.6(1).100033.SCI |
17. Pengfei Li, Xi Zhang, Shumin Wang, Jing Wang, Ziqi Liu, Chen Wang, Weihang Tong* and Lihong Liu*.Development of a rapid LC-MS/MS assay to determine letrozole in human plasma and its application in a pharmacokinetic study after oral administration.ACTA CHROMATOGRAPHICA.2021.34(2).179-184.SCI |
18. Han FF, Ren LL, Xuan LL, Lv YL, Liu H, Gong LL, An ZL, Liu LH*.HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.Cancer Chemother Pharmacol.2021.87(1).103-112.SCI |
19. Rui Zhao# , Zhuoling An# , Yuan Sun , Liangyu Xia , Ling Qiu , Aimin Yao , Yanping Liu**, Lihong Liu*.Metabolic profiling in early pregnancy and associated factors of folate supplementation: A cross-sectional study.Clin Nutr.2021.40(9).5053-5061.SCI |
20. Ping Du, Guoyong Wang, Song Yang, Pengfei Li, Lihong Liu*.Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.Analytical and Bioanalytical Chemistry.2021.413(23).5811-5820.SCI |
21. Zhuoling An*, Chen Shi, Pengfei Li, Lihong Liu*.Stability of amino acids and related amines in human serum under different preprocessing and pre-storage conditions based on iTRAQ ®-LC-MS/MS.Biol Open.2021.10(2).bio055020.SCI |
22. Ximu Sun#, Zhuo Ma#, Qixiang Guo, Zhixia Zhao, Lihong Liu*.Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.European Journal of Cancer.2021.S0959-8049(21).01202-8.SCI |
23. Xin Wang#, Hui Yang#, Xiaopeng Hu, Wei Wang, Xiaojia Yu, Shihui Wang, Xiaodong Zhang*, Lihong Liu*.Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.J Oncol Pharm Pract.2021.27(3).614-622.SCI |
24. Zhuo Ma, Shusen Sun , Caixai Zhang, Xiangzhi Yuan, Qing Chen , Jinling Wu , Xiaojuan Wang *, Lihong Liu*.Characteristics of drug-related problems and pharmacists' interventions in a geriatric unit in China.Int J Clin Pharm.2021.43(1).270-274.SCI |
25. Li-li Gong*, Song Yang, Wen Zhang, Fei-fei Han, Ya-li Lv, Ling-ling Xuan, He Liu, Li-hong Liu*.Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC–MS based lipidomics approach.Journal of Pharmaceutical and Biomedical Analysis.2020.177.112848.SCI |
26. Lingling Xuan, Lulu Ren, Feifei Han, Lili Gong, Zirui Wan, Song Yang, He Liu, Yali Lv*, Lihong Liu*.Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production.Inflammation.2020.43(1).326-335.SCI |
27. Zhikang Ye, Annika Reintam Blaser, Lyubov Lytvyn, Ying Wang, Gordon H. Guyatt, J. Stephen Mikita, Jamie Roberts, Thomas Agoritsas, Sonja Bertschy, Filippo Boroli, Julie Camsooksai, Bin Du, Anja Fog Heen, Jianyou Lu, José M. Mella, Per Olav Vandvik, Robert Wise, Yue Zheng, Lihong Liu*, Reed A.C. Siem.Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.BMJ.2020.368.16722.SCI |
28. Ying Wang, Zhikang Ye, Long Ge, Reed A Siemieniuk, Xin Wang, Yingkai Wang, Liangying Hou, Zhuo Ma, Thomas Agoritsas, Per Olav Vandvik, Anders Perner, Morten H Møller, Gordon H Guyatt, Lihong Liu*.Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.BMJ.2020.368.16744.SCI |
29. Zhuoling An, Ting Hu, Yali Lv, Pengfei Li, Lihong Liu*.Targeted amino acid and related amines analysis based on iTRAQ®-LC-MS/MS for discovering potential hepatotoxicity biomarkers.J Pharm Biomed Anal.2020.178.112812.SCI |
30. Hui Yang, Lizhen Pang, Xiaopeng Hu, Wei Wang, Bifang Xu, Xiaodong Zhang, Lihong Liu*.The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: a systematic review and meta-analysis.J Clin Pharm Ther.2020.45(3).488-495.SCI |
31. Hui Yang#, Yahui Yu#, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang, Xin Feng, Lihong Liu*.Association Between the Overall Risk of Prostate Cancer and Calcium Channel Blockers use: A Systematic Review and Meta-Analysis.Clinical Therapeutics .2020.42(9).1715-1727.SCI |
32. Xin Wang, Shihui Wang, Jing Yang, Xiaojia Yu, Lihong Liu*.Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis.Thromb Res.2020.193.130-138.SCI |
33. Xin Wang, Jing Yang, Xiaojia Yu, Zihui Wang, Huaguang Wang, Lihong Liu*.Characterization of drug-related problems and associated factors in ambulatory patients in China.J Clin Pharm Ther.2020.45(5).1058-1065.SCI |
34. Boyu Li, Yanjin Hu, Guang Wang*, Lihong Liu*.The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study.BMC pharmacology & toxicology.2020.21(1).1-6.SCI |
35. Yahui Yu#, Hui Yang#, Xiaojia Yu, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang, Xin Feng*, Lihong Liu*.Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.Journal of Clinical Pharmacy and Therapeutics.2020.45(6).1325-1333.SCI |
36. Lingling Xuan, Lulu Ren, Feifei Han, Lili Gong, Zirui Wan, Song Yang, He Liu, Yali Lv*, Lihong Liu*.Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production.Inflammation.2020.43(1).326-335.SCI |
37. Lingling Xuan, Feifei Han, Lili Gong, Yali Lv, Zirui Wan, He Liu, Lulu Ren, Song Yang, Wen Zhang, Ting Li, Chunting Tan, Yuan Sun, Benshan Xu, Lihong Liu*.Ceramide Induces MMP-9 Expression Through JAK2/STAT3 Pathway in Airway Epithelium.Lipids Health Dis.2020.19(1).196.SCI |
38. Xin Wang #, Hui Yang #, Shihui Wang, Xiaopeng Hu, Xiaojia Yu, Wei Wang, Xiaodong Zhang *, Lihong Liu *.Comparison of Effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis Running title: Abiraterone versus enzalutamide in mCRPC.Journal of pharmacy and pharmaceutical science.2020.23.451-461.SCI |
39. Zirui Wan#*, Lifang Guo#, Pengfei Li#, Zhixia Zhao, Benshan Xu, Lulu Ren, Yan Yan, He Liu, Yiwen Zhang*, Lihong Liu*.Determinants of Gefitinib Pharmacokinetics in Healthy Chinese Male Subjects: A Pharmacogenomic Study of Cytochrome p450 Enzymes and Transporters.Journal of Clinical Pharmacy and Therapeutics.2020.45(5).1159-1167.SCI |
40. Ting Hu#, Zhuoling An#, Yongkun Sun, Xunqiang Wang, Ping Du, Pengfei Li, Yihebali Chi*, Lihong Liu*.Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy and Toxicity.Frontiers in Oncology.2020.2020.2373.SCI |
41. Ting Hu#, Zhuoling An#, Chen Shi, Pengfei Li, Lihong Liu*.A sensitive and efficient method for simultaneous profiling of bile acids and fatty acids by UPLC-MS/MS.J Pharm Biomed Anal.2020.178.112815.SCI |
42. Ping Du, Ting Hu, Zhuoling An, Pengfei Li, Lihong Liu*.In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.Cancer Science.2020.111(6).1887-1898.SCI |
43. Lifang Guo#, Shumin Wang#, Zirui Wan#, Siyang Ni, Benshan Xu, Xiuli Zhao*,Lihong Liu*.Influence of CYP2D6*5 and *10 polymorphism on the pharmacokinetics of nebivolol in healthy Chinese subjects..Journal of Clinical Pharmacy and Therapeutics.2020.45(4).632-637.SCI |
44. Lulu Ren, Lingling Xuan, Feifei Han, Jie Zhang, Lili Gong, Yali Lv, Wen Zhang, Song Yang, Benshan Xu, Yan Yan, Lifang Guo, He Liu, Zirui Wan*, Lihong Liu*.Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape.Toxicology and Applied Pharmacology.2020.401.115076.SCI |
45. Ping Du, Ting Hu, Zhuoling An, Pengfei Li, Lihong Liu*.Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib.Analyst.2020.145(14).4972-4981.SCI |
46. Ping Du, Pengfei Li, Hongchuan Liu, Rui Zhao, Zhixia Zhao, Weiyue Yu, Xin Zhou, Lihong Liu*.Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.Clinical pharmacology in drug development.2020.9(5).621-628.SCI |
47. Zhuo Ma#, ZhiXia Zhao#, ShuSen Sun, YiFan Li, ZhuoLing An, Yan Yan, LiHong Liu*.Impact of Chief Pharmacist System on drug expenditures and rational drug use.International Journal of Clinical Pharmacy.2020.42(1).167-173.SCI |
48. Ya-li Lv, Yangjie Jia, Zirui Wan, Zhuo-ling An, Song Yang, Fei-fei Han, Li-li Gong, Ling-ling Xuan, Lu-lu Ren, Wen Zhang, He Liu*, Li-hong Liu*.Curcumin inhibits the formation of atherosclerosis in ApoE-/- mice by suppressing human cytomegalovirus activity in endothelial cells.Life Sciences.2020.257.11768.SCI |
49. Zhuo Ma, YaLan Tong , Caixai Zhang, Lihong Liu*.Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients: Comparison of two versions of STOPP/START..J Clin Pharm Ther.2020.45(6).1405-1413.SCI |
50. Yali Lv, Fei-fei Han, Zhuo-ling An, Yangjie Jia, Ling-ling Xuan, Li-li Gong, Wen Zhang, Lu-lu Ren, Song Yang, He Liu*, Li-hong Liu*.Cytomegalovirus infection is a risk factor in gastrointestinal cancer: a cross-sectional and meta-analysis study.Intervirology.2020.63(1-6).10-16.SCI |
51. Dan Liu#, Zhuoling An#, Pengfei Li, Yanhua Chen, Ruiping Zhang, Lihong Liu*, Jiuming He*, Zeper Abliz.A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS.RSC Advances.2020.10.18305-18314.SCI |
52. Fei-fei Han#, Hua Fan#, Lu-lu Ren, Hua-guang Wang, Chunlin Wang, Ma Xu*, Li-hong Liu*, Qiang He*, Chang-long Guo*.Profiling the pattern of human TRB/IGH‐CDR3 repertoire in liver transplantation patients via high‐throughput sequencing analysis.Scandinavian Journal Of Immunology .2020.92(2).e12912.SCI |
53. Li-li Gong, Song Yang, He Liu, Wen Zhang, Lu-lu Ren, Fei-fei Han, Ya-li Lv, Zi-Rui Wan, Li-hong Liu*.Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D.Eur J Pharmacol.2019.845.85-90.SCI |
54. Lifang Guo, Zirui Wan, Benshan Xu, Lulu Ren, He Liu, Nan Song*, Lihong Liu*.Blockade of angiogenin by thalidomide inhibits the tumorigenesis of murine hemangioendothelioma.Fundam Clin Pharmacol.2019.33(6).659-669.SCI |
55. Lifang Guo, Mingbiao Shi, Nan Song, Zirui Wan, He Liu*, Lihong Liu*.Anchorage of curcumin onto PVP enhances anti-tumor effect of curcumin.Medicinal Chemistry Research.2019.28(5).646-656.SCI |
56. Lulu Ren, Feifei Han, Lingling Xuan, Yali Lv, Lili Gong, Yan Yan, Zirui Wan, Lifang Guo, He Liu, Benshan Xu, Yuan Sun,Song Yang, Lihong Liu*.Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation.Free Radical Biology and Medicine.2019.145.357-373.SCI |
57. Ping Du, Pengfei Li, Rui Zhao, Hongchuan Liu, Lihong Liu*..Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study.Bioanalysis.2019.11(13).1291-1302.SCI |
58. Song Yang, Wen Zhang, Ling-ling Xuan, Fei-fei Han, Ya-li Lv, Zi-rui Wan, He Liu, Lu-lu Ren, Li-li Gong∗, Li-hong Liu*.Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells.Atherosclerosis.2019.285.23-30.SCI |
59. Jiaming Fan#, Pengfei Li#, He Liu, Rui Zhao, Zhixia Zhao, Ping Du, Lihong Liu**.Optimized liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of paraquat in plasma: application to a toxicokinetic study.Analytical methods.2019.11(12).2756-2762 .SCI |
60. Ping Du, Yin Guan, Zhuoling An, Pengfei Li, Lihong Liu*..A Selective and robust UPLC-MS/MS method for simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to pharmacokinetic study.Analyst.2019.144(18).5462-5471.SCI |
61. Wen Zhang, Lili Gong, Song Yang, Yali Lv, Feifei Han, He Liu, Lihong Liu*.Lipidomics Profile Changes of Type 2 Diabetes Mellitus with Acute Myocardial Infarction.Disease Markers.2019.2019.doi:10.1155/2019/7614715.SCI |
62. Zhuoling An, Ting Hu, Yali Lv, Pengfei Li, Lihong Liu*.Targeted amino acid analysis based on iTRAQ-LC-MS/MS for discovering potential hepatotoxicity biomarkers.Journal of Pharmaceutical and Biomedical Analysis.2019.178.112812.SCI |
63. Xiangli Cui, Zirui Wan, Zhuo Ma, Lihong Liu*, Yuanhua Yang*.Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report..Medicine (Baltimore).2019.98(10).e14789.SCI |
64. Ying Wang, Zhikang Ye, Lihong Liu*, Xiangli Cui*.Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.J Pharm Pharm Sci.2019.12(1).57-71.SCI |
65. Huaguang Wang, Han Wang, Xiaojia Yu, Hong Zhou, Boyu Li, Gang Chen, Zhikang Ye, Ying Wang, Xiangli Cui, Yunying Zheng, Rui Zhao, Hui Yang, Zihui Wang, Peng Wang, Chunxia Yang, Lihong Liu*.Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study.BMJ Open.2019.9(8).e026072.SCI |
66. Hui Yang, Lili Li, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang*, Lihong Liu*.Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study.J Clin Pharm Ther.2019.44(4).603-610.SCI |
67. 田艳平,崔向丽,刘丽宏*.基于决策树模型对我国6种保肝药物治疗药物性肝损伤的成本-效果分析.中国药物应用与监测.2018.15(3).131-135.核心期刊 |
68. 郑芸颖,王华光,崔向丽,刘丽宏*.碳青霉烯类抗菌药物合理用药的分析.中国临床药理学杂志.2018.34(13).97-99.核心期刊 |
69. 赵志霞,宋 新,李鹏飞,赵 瑞,于伟越,周 鑫,刘丽宏*.生物等效性试验中受试者食用高脂餐的调查研究.中国临床药理学杂志.2018.34(24).85-87.核心期刊 |
70. 郑芸颖,崔向丽,刘丽宏*.酚磺乙胺注射液引发呼吸困难等过敏反应的案例分析.中国临床药理学杂志.2018.34(13).348-349.核心期刊 |
71. 刘洪川,李鹏飞,杜 萍,赵 瑞,于伟越,刘丽宏*.高效液相色谱-质谱联用法测定人血浆中依普利酮浓度.中国临床药理学杂志.2018.34(10).1226-1229.核心期刊 |
72. 陈罡,潘世芬,崔向丽,刘丽宏*."Puerarin attenuates angiotensin II-induced cardiac fibroblasts proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation.Chinese Journal of Natural Medicines.2018.16(1).41-52.SCI |
73. 王颖,叶志康,崔向丽*,刘丽宏*.Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument.Thrombosis research.2018.166.10-18.SCI |
74. 刘洪川,李鹏飞,杜 萍,于伟越,赵 瑞,刘丽宏*.用HPLC-MS/MS法测定人尿液中依普利酮的浓度.药学服务与研究. .2018.18(1).29-32.核心期刊 |
75. 李博宇、王颖、叶志康、杨辉、崔向丽、王振军*、刘丽宏*.Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials .J Pharm Pharm Sci.2018.21(1).225-235.SCI |
76. 王颖,叶志康,崔向丽*,刘丽宏*.Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument.Thrombosis research .2018.166.10-18.SCI |
77. 董亚玲#, 吕亚丽#, 周晓金#, 何林富#, 刘丽宏*, 李鹏飞.Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers .OncoTargets and Therapy.2018.11.1743–1756.SCI |
78. 杨辉,王伟,胡小鹏,张小东*,刘丽宏*.Sirolimus-induced severe small bowel angioedema:A case report.Medicine.2018.97(34).e12029.SCI |
79. 宫丽丽、杨嵩、张文、韩菲菲、吕亚丽、万子睿、刘河、贾阳杰、玄玲玲、刘丽宏*.Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy.Journal of Pharmacological Sciences.2018.136(4).189-195.SCI |
80. 王华光,于晓佳,刘丽宏*.经皮冠状动脉介入治疗术后1例患者的药物重整.药物不良反应杂志.2017.11(241).1019.核心期刊 |
81. 李博宇,崔向丽,邱爽,刘丽宏*.胸腺五肽注射液不合理用药干预分析.中国临床药理学杂志.2017.33(7).653-655.核心期刊 |
82. 杨辉, 尹航, 崔向丽, 刘丽宏*.临床药师在肾内科疾病合理用药中的作用.中国临床药理学杂志.2017.33(13).112-114.核心期刊 |
83. 郭梦园,邱爽*,崔向丽,刘丽宏.临床药师对1 例复发难治多发性骨髓瘤患者开展的药学服务.临床药物治疗杂志.2017.153().55-59.核心期刊 |
84. 杨辉, 崔向丽, 刘丽宏*.美国患者教育模式对我国的借鉴意义.中国临床药理学杂志.2017.33(11).116-118.核心期刊 |
85. 崔向丽,王诗卉,刘丽宏*.案例教学法在临床药师实习教学中的应用.中国临床药理学杂志.2017.33(7).659-661.核心期刊 |
86. 崔向丽1,万子睿1,侯珂露1,杨辉1,于晓佳1,郑芸颖1,刘丽宏1*,杨媛华*.增加肿瘤患者血栓风险的药物概述.中国药物警戒.2017.14(7).1-7.核心期刊 |
87. 郭梦园,崔向丽,刘丽宏*,刘莹.3例精准用药门诊药物治疗管理案例分析.实用药物与临床杂志.2017.20(2).236-240.核心期刊 |
88. 王鑫,崔向丽,杨辉,刘丽宏*.肾移植术后肺部感染的研究现状.中国临床药理学杂志.2017.33(3).276-279.核心期刊 |
89. Xin Wang, Hui Yang, Xiaodong Zhang, Xiangli Cui, Shihui Wang, Lihong Liu*.Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis .J Pharm Pharm Sci.2017.20.168-183.SCI |
90. Li P, Hoppmann S, Du P, Li H, Evans PM, Moestue SA, Yu W, Dong F, Liu H, Liu L*..Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers.Ultrasound Med Biol.2017.43(5).1031-1039.SCI |
91. Li-li Gong, Fei-fei Han, Ya-li Lv, He Liu, Zi-rui Wan, Wen Zhang, Ming-biao Shi, Li-xia Pei, Li-hong Liu*.TNF-alpha and LT-alpha polymorphisms and the risk of leukemia: a meta-analysis..TUMORI.2017.103(1).53-59.SCI |
92. 侯珂露,杨辉,叶志康,王颖,刘丽宏*,崔向丽*.Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis.Journal of Pharmacy & Pharmaceutical Sciences.2017.20.378-396.SCI |
93. Hui Yang, Xiangli Cui, Xin Wang, Shuang Qiu, Lihong Liu*..Clinical Outcomes with Antiviral Prophylaxis or Preemptive Therapy for Cytomegalovirus Disease after Liver Transplantation: A Systematic Review and Meta-Analysis.J Pharm Pharm Sci.2017.20(1).15-27.SCI |
94. Han FF, Lv YL, Gong LL, Liu H, Wan ZR, Liu LH*..VDR Gene variation and insulin resistance related diseases..Lipids Health Dis.2017.16(1).157.SCI |
95. Yang-jie Jia, Jun Liu, Fei-fei Han, Zi-rui Wan, Li-li Gong, He Liu, Wen Zhang, Thomas Wardell, Ya-li Lv*,, Li-hong Liu* .Cytomegalovirus infection and atherosclerosis risk: a meta-analysis.J Med Virol.2017.89(12).2196-2206.SCI |
96. Ya-li Lv, Fei-fei Han, Yang-jie Jia , Zi-rui Wan ,Li-li Gong, He Liu, Li-hong Liu*.. Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis..Infection and Drug Resistance.2017.10.511–519.SCI |
97. Ya-li Lv, Fei-fei Han, Li-li Gong, He Liu, Jun Ma, Wei-yue Yu, Zi-rui Wan, Yang-jie Jia, Wen Zhang, Mingbiao Shi, Li-hong Liu*.Human cytomegalovirus infection and vascular disease risk: A meta-analysis.Virus Research.2017.227.124-134.SCI |
98. Gong LL, Liu H, Liu LH*.Relationship between hypothyroidism and the incidence of gestational diabetes: A meta-analysis..Taiwan J Obstet Gynecol..2016.55(2).171-175.SCI |
99. Zhi-Kang Ye, Ying Liu, Xiang-Li Cui, Li-Hong Liu*.Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis.PLoS ONE.2016.11(5).e0155020.SCI |
100. Hui Yang, Xiangli Cui, Zhuo Ma, Lihong Liu*.Evaluation Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis.J Pharm PharmSci.2016.19(2).274-289.SCI |
101. Gong LL, Li GR, Zhang W, Liu H, Lv YL, Han FF, Wan ZR, Shi MB, Liu LH*.AkebiaSaponin D Decreases Hepatic Steatosis through Autophagy Modulation..J Pharmacol Exp Ther..2016.359(3).392-400.SCI |
102. Gong LL,Han FF, Lv YL, Liu H, Wan ZR, Zhang W,ShiMB,PeiLX,Liu LH*.TNF-α and LT-α polymorphisms and the risk of leukemia: a meta-analysis..Tumori..2016.103(1).53-59.SCI |
103. YALI LV, LILI GONG, ZIHUI WANG, FEIFEI HAN, HE LIU, XUECHUN LU, LIHONG LIU*.Curcumin inhibits human cytomegalovirus bydownregulating heat shock protein 90 .MOLECULAR MEDICINE REPORTS.2015.12(3).4789-4793.SCI |
104. Gang Chen, Qiang Cao, Xiangli Cui, Shifen Pan, Chong Shen, Lihong Liu*.Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.Journal of pharmacy and pharmaceutical sciences.2015.18(2).235 - 248.SCI |
105. 李广润,宫丽丽,吕亚丽,刘丽宏* .川续断皂苷Ⅵ药理作用研究进展.中国新药与临床杂志.2014.33(7).477-480.核心期刊 |
106. 王华光,刘丽宏*.临床药师参与抗菌药物使用管理的经验和体会.药学服务与研究.2014.14(2).101-103.核心期刊 |
107. 李广润,宫丽丽,吕亚丽,刘河,韩菲菲,王子惠,刘丽宏*.川续断皂苷VI对非酒精性脂肪肝小鼠的降脂作用研究.时珍国医国药.2014.25(8).1800-1802.核心期刊 |
108. Lv Y, An Z, Chen H, Wang Z, Liu L*.Mechanism of curcumin resistance to human cytomegalovirus in HELF cells.BMC Complement Altern Med..2014.14.284.SCI |
109. Han FF, Fan H, Wang ZH, Li GR, Lv YL, Gong LL, Liu H, He Q*, Liu LH*.Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft.Transpl Immunol.2014.31(2).81-86.SCI |
110. Pengfei Li, Beibei Tao, Xude Zhang, Zhuoling An, Xi Zhang, Yue Li, Hao Qianqian, Lihong Liu*.High-flux Detection of 30 Kinds Amino Acids with Isotope-Labeled Internal Standard by LC-MS/MS..Chinese Journal of Analytical Chemistry.2013.41(9).1347-1352.SCI |
111. 张征, 李馨, 李鹏飞, 于晓佳, 邱葵, 罗薇, 刘丽宏*.中毒患者血浆中百草枯的LC-MS/MS定量检测方法研究.国际检验医学杂志.2013.34(11).1380-1381.核心期刊 |
112. 张茜, 李鹏飞, 吕亚丽, 安卓玲, 吴诚, 李广润, 刘丽宏*.硝胺推进剂在大鼠体内代谢动力学及病理学研究.国际检验医学杂志.2013.34(3).263-265.核心期刊 |
113. Li-Li Gong, Lian-Hua Fang, He-Yao Wang, Jian-Hao Peng, Kun Si, Jin Zhu, Fei-Fei Han, Yue-Hua Wang, Guan-Hua Du*, Li-Xia Pei, Li-Hong Liu*. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.Steroid.2013.2013(78).401-408.SCI |
114. 张征, 刘颖, 张倩, 刘丽宏*.荧光素钠注射液致不良反应55例分析.中国药房.2013.24(44).4189-4191.核心期刊 |
115. 陈慧, 童卫杭, 刘丽宏*.盐酸吉西他滨致手足综合征1例.中国医院药学杂志.2013.33(9).755-756.核心期刊 |
116. 路敏, 雷宁, 吕亚丽, 吴诚, 李超, 刘丽宏*.续断皂苷类成分的体外抗氧化活性研究.北京师范大学学报:自然科学版.2013.49(1).42-45.核心期刊 |
117. 李鹏飞, 王淑民, 张茜, 安卓玲, 刘丽宏*.LC-MS/MS法测定人血浆中氨基葡萄糖的浓度.首都医科大学学报.2013.34(5).715-719.核心期刊 |
118. 罗薇, 王鹤尧*, 刘丽宏*, 李鹏飞, 祝锦, 宫丽丽.CYP2C19多态性对奥美拉唑药代动力学的影响.临床药物治疗杂志.2013.11(2).22-26.核心期刊 |
119. Fei-fei Han, Chang-long Guo, Li-Li Gong, Jin Zhu, Li-hong Liu*.Effects of the NQO1 609C>T Polymorphism on Leukemia Susceptibility: Evidence from a Meta-analysis.Asian Pacific Journal of Cancer Prevention.2013.14(9).5311-5316.SCI |
120. Fei-fei Han, Chang-long Guo, Li-hong Liu*.The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis.DNA and Cell Biology.2013.32(6).329-335.SCI |
121. 吴诚, 李鹏飞, 王燕, 雷宁, 吕亚丽, 刘丽宏*.液相色谱-质谱联用法测定大鼠血浆中木通皂苷D的浓度.国际药学研究杂志.2012.39(3).261-264.核心期刊 |
122. 王波, 李鹏飞, 马萍, 王燕, 刘丽宏*.LC-MS/MS和荧光偏振法监测环孢素A血药浓度的相关性研究.质谱学报.2012.33(1).28-31.核心期刊 |
123. 马萍, 李鹏飞, 王淑民, 汪娟, 王燕, 谢晓娟, 刘丽宏*.克拉霉素软胶囊在中国健康人体的生物等效性研究.中国临床药理学与治疗学.2012.17(4).433-437.核心期刊 |
124. Pengfei Li, Yan Wang, Beibei Tao, Jing Wang, Jing Luo, Xude Zhang, Zhuoling An, Lihong Liu*.Simultaneous Determination of 42 Amino Acids in Human Body by Stable Isotope Isobaric Tage for Relative and Absolute Quantitation Labeled-LC-MS/MS with Typical Example Cases.Chinese Journal of Analytical Chemistry.2012.40(5).762-767.SCI |
125. 安卓玲, 李鹏飞, 迟小华, 张茜, 马萍, 刘丽宏*.肼引发损伤相关小分子代谢物的研究进展.中国药理学通报.2012.28(6).754-756.核心期刊 |
126. Pengfei Li, Ping Ma, Yan Wang, Weihang Tong, Jing Wang, Cheng Wu, Lihong Liu*.Liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of palonosetron in human plasma and urine: Application to a pharmacokinetic study .Journal of Chromatography B.2012.895-896.10-6.SCI |
127. Peng-Fei Li, Jian-Zi Sun, Ling Wang, Ya-Li Lv, Li-Hong Liu*.3,5-Bis(adamantan-1-yl)-1 -methoxy-benzene.Acta Crystallographica Section E.2012.E68.01182.SCI |
128. 吕亚丽, 蓝苑元, 王丹, 雷宁, 刘丽宏*.姜黄素体外抗人巨细胞病毒活性的研究.中药新药与临床药理.2012.23(5).531-533.核心期刊 |
129. Li-Li Gong, Jian-Hao Peng, Fei-Fei Han, Jin Zhu, Lian-Hua Fang, Yue-Hua Wang, Guan-Hua Du*, He-Yao Wang*, Li-Hong Liu*.Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.Thrombosis Research.2012.130(3).e43-51.SCI |
130. 王燕, 李鹏飞, 马萍, 安卓玲, 胡范文, 刘丽宏*. LC-MS/MS法检测他克莫司血药浓度室内质控回顾性分析.国际检验医学杂志.2012.33(15).1873-1875.核心期刊 |
131. Ya-li LV, An-jie LAN, Yuan-yuan LAN, Chao LI, Ning LEI, Cheng WU and Li-hong LIU*.Activity of curcumin against human cytomegalovirus in vitro.African Journal of Pharmacy and Pharmacology.2012. 6(1).30-35.SCI |
132. Kang Meng, Miao Cao, Zhuo-Ling An, Jie Zhang, Li-Hong Liu*.(5-Bromo-2-hydroxyphenyl)(4-propyl-cyclohexyl) methanone.Acta Crystallographica Section E.2012.E68.01181.SCI |
133. 雷宁, 王玲, 孙健姿, 吴诚, 刘丽宏*.六味参苓颗粒的质量标准研究.中国药房.2012.23(35).3328-3330.核心期刊 |
134. 王燕, 李鹏飞, 马萍, 安卓玲, 张茜, 罗恋, 刘丽宏*.LC-MS/MS法测定人血浆中氨氯地平的浓度.质谱学报.2012.33(3).181-185.核心期刊 |
135. 李鹏飞, 孙健姿, 马萍, 王燕, 王静, 张茜, 谢小娟, 刘丽宏*.LC-MS/MS法测定人血浆中克拉霉素的质量浓度.北京师范大学学报:自然科学版.2012.48(4).323-326.核心期刊 |
136. 马萍, 李鹏飞, 童卫杭, 孙健姿, 吴诚, 刘丽宏*.氯沙坦钾片在健康人体的生物等效性.中国临床药理学杂志.2012.28(3).179-182.核心期刊 |
137. 李鹏飞, 王燕, 童卫杭, 马萍, 兰安杰, 刘丽宏*.液相色谱-串联质谱法测定人血浆中多潘立酮浓度.中国临床药理学杂志.2012.28(3).208-211.核心期刊 |
138. 蓝苑元, 罗恋, 吕亚丽, 马萍, 刘丽宏*.姜黄素自微乳化制剂制备及其稳定性研究.中国药师.2012.15(2).173-177.核心期刊 |
139. 李超, 张晓菲, 吕亚丽, 蓝苑元, 雷宁, 刘丽宏*.木通皂苷D对CCl4致小鼠急性肝损伤的保护作用.华西药学杂志.2012.27(3).257-259.核心期刊 |
140. 童卫杭, 温洁怡, 宝玉荣, 李鹏飞, 马萍, 王燕, 刘丽宏*.来曲唑片在中国健康人体的生物等效性.中国临床药理学杂志.2012.28(2).131-134.核心期刊 |
141. Xiao-fei Zhang, Chun-lei Ding, He Liu, Li-hong Liu*.Protective effects of ion-imprinted chitooligo-saccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells.Toxicology.2011.286(1-3).75-84.SCI |
142. Kang Meng, Cheng Wu, Jing Cao, Ping Ma, Lihong Liu*.Bis(4-ethoxyphenyl) sulfoxide.Acta Crystallographica Section E.2011.E67.01136.SCI |